Research progress and clinical implications of isavuconazole in the treatment of pediatric mucormycosis
Mucormycosis is an infectious disease caused by fungi in the order Mucorales. Due to its high mortality rate and limited treatment options, treating mucormycosis in children remains challenging. Isavuconazole, a novel triazole antifungal agent, has offered a new option for treating mucormycosis. Tho...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Chinês |
| Опубліковано: |
Editorial Office of Journal of Clinical Pediatrics
2026-06-01
|
| Серія: | Linchuang erke zazhi |
| Предмети: | |
| Онлайн доступ: | https://jcp.xinhuamed.com.cn/fileup/1000-3606/PDF/1780540878819-1951792070.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|